PTX3 and Miyoshi myopathy: However, the in vitro data hereby reported, and previous observations from others [21], have shown that endogenous PTX3 overexpression or recombinant PTX3 treatment do not affect the survival and proliferation of MM cells under standard cell suspension culture conditions.